These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16381233)
1. [Factors influencing clinical course of viral hepatitis]. Mise S Acta Med Croatica; 2005; 59(5):393-6. PubMed ID: 16381233 [TBL] [Abstract][Full Text] [Related]
2. [Hepatitis B and C: natural course of disease]. Vince A Acta Med Croatica; 2005; 59(5):389-92. PubMed ID: 16381232 [TBL] [Abstract][Full Text] [Related]
3. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381 [TBL] [Abstract][Full Text] [Related]
4. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. Chu CJ; Lee SD J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482 [TBL] [Abstract][Full Text] [Related]
6. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients. Kumar R; Singla V; Kacharya Sk Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605 [TBL] [Abstract][Full Text] [Related]
8. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal. Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534 [TBL] [Abstract][Full Text] [Related]
10. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database. Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM; J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study. Vaiphei K; Pal NS; Arora SK Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology, natural history, and treatment of hepatitis B virus and hepatitis C virus coinfection. Perumalswami PV; Bini EJ Minerva Gastroenterol Dietol; 2006 Jun; 52(2):145-55. PubMed ID: 16557186 [TBL] [Abstract][Full Text] [Related]
15. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C and diabetes: the inevitable coincidence? Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243 [TBL] [Abstract][Full Text] [Related]
17. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655 [TBL] [Abstract][Full Text] [Related]
18. Review article: chronic hepatitis C--natural history and cofactors. Alberti A; Vario A; Ferrari A; Pistis R Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():74-8. PubMed ID: 16225479 [TBL] [Abstract][Full Text] [Related]
19. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy. Chehadeh W; Al-Nakib W J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842 [TBL] [Abstract][Full Text] [Related]
20. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Su CW; Huang YH; Huo TI; Shih HH; Sheen IJ; Chen SW; Lee PC; Lee SD; Wu JC Gastroenterology; 2006 May; 130(6):1625-35. PubMed ID: 16697726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]